Moderna Backtracks to Open Covid Vaccine Trial to Those With HIV

Bookmark
(Bloomberg) -- After pressure from advocates in recent weeks, Moderna Inc. will now allow individuals living with HIV to be part of a late-stage clinical trial of its Covid-19 vaccine candidate.